Sartorius Stedim Biotech launches new SIMCA 16 software for multivariate data analytics

Sartorius Stedim Biotech (SSB), a leading international partner of the biopharmaceutical industry today announced the new SIMCA® 16 software for multivariate data analytics is available from its subsidiary Sartorius Stedim Data Analytics. The updated SIMCA® focuses on delivering a complete data analysis experience, from data organization through to data-driven decision making, supported by multivariate models for single and multiblock analysis.

The new SIMCA® 16 software has enhanced functionality features which will save time for expert users, as well as those new to multivariate data analysis. Usability improvements provide novices with an intuitive introduction to SIMCA® and existing users with superior plot interactivity and quick raw data visualization capabilities. The software’s updated graphical interface with its context-based ribbons and panes means scientists will spend less time looking for functions and the new ribbons will be especially useful for those working with batch data. The new data analytics software also includes a wizard that adapts to users’ modeling objectives (rather than focusing on which algorithm to use) and guides them through set-up, making the initial steps of creating each model easier. Additionally, its advanced data merging functionality saves time by eliminating the need to manually combine and align data in Excel.

To make pattern data in models easier to interpret and use, SIMCA® 16 comes with novel score space exploration and multivariate solver tools which help turn models into real-life factor combinations. In just one click, the score space exploration tool allows users to convert scatter plots into real factor settings to for example, detect which sample is missing in a stack of observations. With the multivariate solver tool, scientists can determine optimum factor settings for desired process outputs such as Critical Quality Attributes and can also lock model parameters to a specific batch of raw material to find the process parameters for achieving consistent product quality and operational efficiency. Both tools make trouble shooting process data and performing deviation analysis simpler tasks.

To increase application and functional flexibility, SIMCA® 16 includes MOCA, a novel tool for analyzing more than two blocks of data and new Python plugin capability. MOCA provides a quick overview of an entire system, delivering invaluable information for continuing analysis, and is ideal for scientists such as systems biologists wanting to compare data from one system that has been obtained using different “omics” and other techniques.

The Python plugin functionality in SIMCA® 16 provides greater workflow flexibility by enabling users to create a file reader plugin which can read files like any other file format as they are being imported. This is especially useful when scientists need to transfer data from a new instrument with a non-standard export format or from text files where data is not configured correctly for SIMCA®, saving them time and effort with pre-processing and importing data.

Developing and producing biotherapeutics generates a vast array of process data in different formats from a variety of equipment types. This data holds the key to improving performance but can be challenging to input, model and interpret. We’re pleased to introduce our new SIMCA® 16 because it offers elevated levels of control over data, model generation and decision making, enabling scientists to optimize resource use and cost efficiency, while more importantly, achieving consistency in their product quality.”

Stefan Rännar, Product Manager at Sartorius Stedim Data Analytics

The use of SIMCA® is recognized by the EMA and US FDA for Real-Time Release testing and the SIMCA® 16 software have been developed and extensively tested and validated for use in a highly-regulated environment.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sartorius. (2019, June 19). Sartorius Stedim Biotech launches new SIMCA 16 software for multivariate data analytics. News-Medical. Retrieved on December 22, 2024 from https://www.news-medical.net/news/20190509/Sartorius-Stedim-Biotech-launches-new-SIMCA-16-software-for-multivariate-data-analytics.aspx.

  • MLA

    Sartorius. "Sartorius Stedim Biotech launches new SIMCA 16 software for multivariate data analytics". News-Medical. 22 December 2024. <https://www.news-medical.net/news/20190509/Sartorius-Stedim-Biotech-launches-new-SIMCA-16-software-for-multivariate-data-analytics.aspx>.

  • Chicago

    Sartorius. "Sartorius Stedim Biotech launches new SIMCA 16 software for multivariate data analytics". News-Medical. https://www.news-medical.net/news/20190509/Sartorius-Stedim-Biotech-launches-new-SIMCA-16-software-for-multivariate-data-analytics.aspx. (accessed December 22, 2024).

  • Harvard

    Sartorius. 2019. Sartorius Stedim Biotech launches new SIMCA 16 software for multivariate data analytics. News-Medical, viewed 22 December 2024, https://www.news-medical.net/news/20190509/Sartorius-Stedim-Biotech-launches-new-SIMCA-16-software-for-multivariate-data-analytics.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology